Press What’s news at AbelsonTaylor Group
Select category
Moving Into 2024
Applying his background in pharmacology, Jeff Berg, President of AbelsonTaylor Group, discusses a particularly exciting use of AI in drug discovery that is tackling one of biology’s biggest challenges – predicting the 3D shape of proteins and designing them from scratch. Read more at https://www.pharmalive.com/healthcare-agency-roundtable-2024-moving-into-2025/
Media Contact:
Recent Posts
Sara Brandt Joins AbelsonTaylor Group as SVP, Head of Media for ATActivate
CHICAGO – November 4, 2025 – AbelsonTaylor Group, a leading independent healthcare marketing and communications agency, is proud to announce...
Read Press Read more Sara Brandt Joins AbelsonTaylor Group as SVP, Head of Media for ATActivateWhat Pharma Can Teach Every Marketer About Risk, Regulation and Trust
What happens when regulation, trust, and creativity collide in healthcare marketing? In his latest guest post for the 4A’s and...
In the News Read more What Pharma Can Teach Every Marketer About Risk, Regulation and TrustElsa Varghese, M.D., Joins AbelsonTaylor Group as Medical Strategy Director
CHICAGO – October 16, 2025 — AbelsonTaylor Group, a leading independent healthcare marketing and communications agency, is pleased to announce...
Read Press Read more Elsa Varghese, M.D., Joins AbelsonTaylor Group as Medical Strategy DirectorConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.